In The News Posted February 1, 2019 Share Posted February 1, 2019 LEAMINGTON, ON, Feb. 1, 2019 /PRNewswire/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) has completed its first transfer of plant cuttings from four of the Company's cannabis strains to Denmark-based Schroll Medical ("Schroll"), as part of the Company's previously... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.